Bruker Announces Resignation of Chief Financial Officer and Appointment of Interim Chief Financial Officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Jefferies Remains Bullish in the Wake of Bruker's (BRKR) Surprise CFO Departure
May 21, 2015 7:50 AM EDTJefferies maintains a Buy rating and $25 price target on Bruker (NASDAQ: BRKR) following the surprise departure of CFO, Charlie Wagner. It was announced last night that Wagner will be stepping down as CFO next month to join Ortho-Clinical Diagnostics (OCD) as CFO. Analyst Brandon Couillard believes that the departure will have a negative psychological impact... More
William Blair Downgrades Bruker (BRKR) to Market Perform
May 21, 2015 6:43 AM EDTWilliam Blair downgraded Bruker (NASDAQ: BRKR) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Bruker click here. For more ratings news on Bruker click here.
Shares of Bruker closed at $22.21 yesterday.
... MoreBruker (BRKR) CFO Wagner to Resign
May 20, 2015 4:10 PM EDTBruker Corporation (NASDAQ: BRKR) announced that on May 19, 2015, Mr. Charles F. Wagner, Jr., Executive Vice President and the Chief Financial Officer (CFO) of Bruker since July 2012, submitted his resignation, effective June 12, 2015, in order to pursue other interests. Mr. Wagner has informed the Company that he has accepted a position as Chief Financial Officer of Ortho-Clinical Diagnostics, Inc., and will commence service in that position in late June 2015. Mr. Wagners resignation is not the result of any dispute or disagreement with the Company or any matter relating to the Companys accounting practices or financial... More
